ABBV vs HUM
By Alex · Tickerpine
AbbVie Inc. vs Humana Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | HUM |
|---|---|---|
| Price | $295.03 | $450.00 |
| Market cap | $521.50B | $54.05B |
| P/E ratio | 50.7 | 43.9 |
| ROE | — | 6.74% |
| Profit margin | 15.67% | 0.81% |
| Revenue growth | 10.30% | 26.10% |
| Dividend yield | 2.35% | 0.79% |
| Beta | 0.19 | 0.64 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs HUM in plain English
- ABBV is the bigger company — about 9.6× the market cap of HUM.
- HUM is cheaper on earnings (P/E 43.9 vs 50.7).
- HUM is growing revenue faster (26% vs 10%).
- ABBV has the higher dividend yield (2.35% vs 0.79%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
HUM return calculator
See what $1,000 in Humana Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.